After months of teasing, Tesla has finally revealed its cheapest Model Y yet that comes with less to offer—the most important of which is less price. As it turns out, Tesla was doing similar things to ...
Australian selectors are pondering a top order reshuffle for this summer’s Ashes series, possibly moving Steve Smith to No.3, Cameron Green to No.4 with Marnus Labuschagne opening the batting, ...
Marnus Labuschagne has sent national selectors a strong message with a Sheffield Shield century for Queensland against Tasmania at Brisbane’s Allan Border Field, even if it did come with a few slices ...
Marnus Labuschagne credited Steve Smith's influence for helping him rebuild his game after he was dropped from the Australian Test team. Labuschagne took a major step towards reclaiming his berth for ...
LONGUEUIL — A trial for a former employee of Quebec's electricity utility accused of economic espionage on behalf of China was delayed Monday as Hydro-Québec announced it wanted to prevent some ...
David Edwards has spent over a decade reporting on social justice, human rights and politics for Raw Story. He also writes Crooks and Liars. He has a background in enterprise resource planning and ...
After rain ruined most of day one, 14 wickets fell on Sunday in Perth to put the visitors narrowly in front. Resuming on 35 for 3, New South Wales were dismissed for 170 and then had Western Australia ...
Day 3 of the 2025 Buildcorp Australian Rugby Shield is run and done with 2024 winners Queensland Country Heelers and ACT & SNSW Kestrels locking in their final berths The Women's Shield final has been ...
India’s electric two-wheeler market clocked 96,031 registrations in September, with TVS Motor emerging as the top seller. Ather Energy broke into the top three for the first time, edging out Ola ...
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Guardant Health, Inc. is one of them. Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, ...
PETACH TIKVA, Israel, Sept. 30, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results